|
|
||||||||
AJP - Cell Physiology, Vol 256, Issue 4 C799-C806, Copyright © 1989 by American Physiological Society
ARTICLES |
G. H. Moser, J. Schrader and A. Deussen
Zentrum fur Physiologie und Klinische Physiologie, Universitat Dusseldorf, Federal Republic of Germany.
To determine half-life and turnover of plasma adenosine, heparinized blood from healthy volunteers was incubated with radiolabeled adenosine in the physiological concentration range of 0.1-1 microM. Plasma levels of adenosine in vitro were 82 +/- 14 nM and were similar to those determined immediately after blood collection with a "stopping solution." Dipyridamole (83 microM) and erythro-9(2-hydroxynon-3yl)-adenine (EHNA) (8 microM) did not measurably alter basal adenosine levels but completely blocked the uptake of added adenosine. Inhibition of ecto-5'-nucleotidase with 100 microM alpha, beta-methyleneadenosine 5'-diphosphate (AOPCP) reduced plasma adenosine to 22 +/- 6 nM. For the determination of adenosine turnover, the decrease in specific radioactivity of added [3H]adenosine was measured using a dipyridamole-containing stopping solution. Without altering basal adenosine levels, the half-life was estimated to be 0.6 s. Similar experiments were carried out with washed erythrocytes or in the presence of AOPCP, yielding half-lives of 0.7 and 0.9 s, respectively. When the initial adenosine concentration was 1 microM, its specific activity decreased by only 11% within 5 s, whereas total plasma adenosine exponentially decreased with a half-life of 1.5 s. Venous plasma concentrations were measured after relief of a 3-min forearm ischemia. Changes in plasma adenosine did not correlate well with changes in blood flow but were augmented in the presence of dipyridamole.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
I. Heinonen, S. V. Nesterov, K. Liukko, J. Kemppainen, K. Nagren, M. Luotolahti, P. Virsu, V. Oikonen, P. Nuutila, U. M. Kujala, et al. Myocardial blood flow and adenosine A2A receptor density in endurance athletes and untrained men J. Physiol., November 1, 2008; 586(21): 5193 - 5202. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barden, L. Lawrenson, J. G. Poole, J. Kim, D. W. Wray, D. M. Bailey, and R. S. Richardson Limitations to vasodilatory capacity and VO2 max in trained human skeletal muscle Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2491 - H2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Collins and S. E. DiCarlo Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1020 - H1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Riksen, E. E. M. van Ginneken, P. H. H. van den Broek, P. Smits, and G. A. Rongen In vivo evidence against a role for adenosine in the exercise pressor reflex in humans J Appl Physiol, August 1, 2005; 99(2): 522 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Montesinos, A. Desai, J.-F. Chen, H. Yee, M. A. Schwarzschild, J. S. Fink, and B. N. Cronstein Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors Am. J. Pathol., June 1, 2002; 160(6): 2009 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noji, M. Takayama, M. Mizutani, Y. Okamura, H. Takai, A. Karasawa, and H. Kusaka KF24345, an Adenosine Uptake Inhibitor, Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Production and Leukopenia via Endogenous Adenosine in Mice J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Smolenski, O. Raisky, E. M. Slominska, H. Abunasra, K. K. Kalsi, J. Jayakumar, K. Suzuki, and M. H. Yacoub Protection From Reperfusion Injury After Cardiac Transplantation by Inhibition of Adenosine Metabolism and Nucleotide Precursor Supply Circulation, September 18, 2001; 104(90001): I-246 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, L. M. Riou, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and ATL146e Administered by Either Intravenous Infusion or Bolus Injection Circulation, September 4, 2001; 104(10): 1181 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Boyle, E. A. Kowaluk, M. F. Jarvis, C.-H. Lee, S. S. Bhagwat, M. Williams, and G. S. Firestein Anti-Inflammatory Effects of ABT-702, a Novel Non-Nucleoside Adenosine Kinase Inhibitor, in Rat Adjuvant Arthritis J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 495 - 500. [Abstract] [Full Text] |
||||
![]() |
L. M. Gervitz, L. O. Lutherer, D. G. Davies, J. H. Pirch, and J. C. Fowler Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R639 - R645. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Costa, A. Diedrich, B. Johnson, P. Sulur, G. Farley, and I. Biaggioni Adenosine, a Metabolic Trigger of the Exercise Pressor Reflex in Humans Hypertension, March 1, 2001; 37(3): 917 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Penttila, M. V.K. Lepojarvi, K. T. Kiviluoma, P. K. Kaukoranta, I. E. Hassinen, and K. J. Peuhkurinen Myocardial preservation during coronary surgery with and without cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2001; 71(2): 565 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. MacLean, L. M. Vickery, and L. I. Sinoway Elevated interstitial adenosine concentrations do not activate the muscle reflex Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H546 - H553. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Siegmund, F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G. S. Firestein, D. Boyle, H.-A. Lehr, F. Loher, G. Hartmann, et al. Adenosine Kinase Inhibitor GP515 Improves Experimental Colitis in Mice J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 99 - 105. [Abstract] [Full Text] |
||||
![]() |
S. Mattig and A. Deussen Significance of adenosine metabolism of coronary smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H117 - H124. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, L. Belardinelli, J. A. Zablocki, V. Palle, and J. C. Shryock A partial agonist of the A1-adenosine receptor selectively slows AV conduction in guinea pig hearts Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H334 - H343. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawashima, T. Nagasawa, and H. Ninomiya Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells Blood, September 15, 2000; 96(6): 2157 - 2162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eigler, V. Matschke, G. Hartmann, S. Erhardt, D. Boyle, G. S. Firestein, and S. Endres Suppression of TNF-{alpha} production in human mononuclear cells by an adenosine kinase inhibitor J. Leukoc. Biol., July 1, 2000; 68(1): 97 - 103. [Abstract] [Full Text] |
||||
![]() |
F. Costa, J. Heusinkveld, R. Ballog, S. Davis, and I. Biaggioni Estimation of Skeletal Muscle Interstitial Adenosine During Forearm Dynamic Exercise in Humans Hypertension, May 1, 2000; 35(5): 1124 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Carey Cellular adaptations in fat tissue of exercise-trained miniature swine: role of excess energy intake J Appl Physiol, March 1, 2000; 88(3): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. FLAMAND, S. BOUDREAULT, S. PICARD, M. AUSTIN, M. E. SURETTE, H. PLANTE, E. KRUMP, M.-J. VALLEE, C. GILBERT, P. NACCACHE, et al. Adenosine, a Potent Natural Suppressor of Arachidonic Acid Release and Leukotriene Biosynthesis in Human Neutrophils Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S88 - 94. [Full Text] [PDF] |
||||
![]() |
G A Ng, W Martin, and A C Rankin Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy Heart, August 1, 1999; 82(2): 163 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Costa, P. Sulur, M. Angel, J. Cavalcante, V. Haile, B. Christman, and I. Biaggioni Intravascular Source of Adenosine During Forearm Ischemia in Humans : Implications for Reactive Hyperemia Hypertension, June 1, 1999; 33(6): 1453 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Cronstein, M. C. Montesinos, and G. Weissmann Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappa B PNAS, May 25, 1999; 96(11): 6377 - 6381. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yada, K. N. Richmond, R. van Bibber, K. Kroll, and E. O. Feigl Role of adenosine in local metabolic coronary vasodilation Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1425 - H1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deussen, M. Stappert, S. Schafer, and M. Kelm Quantification of Extracellular and Intracellular Adenosine Production : Understanding the Transmembranous Concentration Gradient Circulation, April 20, 1999; 99(15): 2041 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Penttila, M. V.K. Lepojarvi, P. K. Kaukoranta, K. T. Kiviluoma, K. V. Ylitalo, and K. J. Peuhkurinen Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass Ann. Thorac. Surg., March 1, 1999; 67(3): 683 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. SAITO, M. NISHIMURA, H. SHINANO, H. MAKITA, I. TSUJINO, E. SHIBUYA, F. SATO, K. MIYAMOTO, and Y. KAWAKAMI Plasma Concentration of Adenosine during Normoxia and Moderate Hypoxia in Humans Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 1014 - 1018. [Abstract] [Full Text] |
||||
![]() |
P. F. Lennon, C. T. Taylor, G. L. Stahl, and S. P. Colgan Neutrophil-derived 5'-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation J. Exp. Med., October 19, 1998; 188(8): 1433 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hata, P. Whittaker, R. A. Kloner, and K. Przyklenk Brief Antecedent Ischemia Attenuates Platelet-Mediated Thrombosis in Damaged and Stenotic Canine Coronary Arteries : Role of Adenosine Circulation, February 24, 1998; 97(7): 692 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Krump, S. Picard, J. Mancini, and P. Borgeat Suppression of Leukotriene B4 Biosynthesis by Endogenous Adenosine in Ligand-activated Human Neutrophils J. Exp. Med., October 20, 1997; 186(8): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Maclean, B. Saltin, G. Radegran, and L. Sinoway Femoral arterial injection of adenosine in humans elevates MSNA via central but not peripheral mechanisms J Appl Physiol, October 1, 1997; 83(4): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Middlekauff, E. U. Nitzsche, A. H. Nguyen, C. K. Hoh, and G. G. Gibbs Modulation of Renal Cortical Blood Flow During Static Exercise in Humans Circ. Res., January 1, 1997; 80(1): 62 - 68. [Abstract] [Full Text] |
||||
![]() |
D. W. Stepp, R. Van Bibber, K. Kroll, and E. O. Feigl Quantitative Relation Between Interstitial Adenosine Concentration and Coronary Blood Flow Circ. Res., September 1, 1996; 79(3): 601 - 610. [Abstract] [Full Text] |
||||
![]() |
H. M. Siragy and J. Linden Sodium Intake Markedly Alters Renal Interstitial Fluid Adenosine Hypertension, March 1, 1996; 27(3): 404 - 407. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |